首页 > 最新文献

Regenerative medicine最新文献

英文 中文
Expression of CD45 in non-hematopoietic cells: implications in regenerative medicine and disease management. 非造血细胞中 CD45 的表达:对再生医学和疾病管理的影响。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2024-01-01 Epub Date: 2024-07-26 DOI: 10.1080/17460751.2024.2378627
Madhurima Das, Prajakta Teli, Anuradha Vaidya, Vaijayanti Kale

CD45 plays a crucial role in the regulation of hematopoiesis. However, a comprehensive understanding of its role in non-hematopoietic cells is lacking. Several tissue precursors express CD45, indicating its crucial role in tissue regeneration. These precursors would fall prey to the recent therapies involving CD45 as a target. CD45+ double-positive tumor cells contribute to cancer progression, but whether CD45 is involved in the process needs to be investigated. Recently, we showed that aging induces CD45 expression in mesenchymal stromal cells and affects their differentiation potential. In this review, we, for the first time, unravel the important implications of the expression of CD45 in non-hematopoietic cells and provide novel insights into its potential therapeutic target in regenerative medicine and disease management.

CD45 在调节造血过程中发挥着至关重要的作用。然而,人们对其在非造血细胞中的作用还缺乏全面的了解。一些组织前体表达 CD45,表明它在组织再生中起着关键作用。这些前体细胞会成为最近以 CD45 为靶点的疗法的牺牲品。CD45+ 双阳性肿瘤细胞有助于癌症进展,但 CD45 是否参与了这一过程还有待研究。最近,我们发现衰老会诱导间充质基质细胞中 CD45 的表达,并影响其分化潜能。在这篇综述中,我们首次揭示了 CD45 在非造血细胞中表达的重要意义,并对其在再生医学和疾病治疗中的潜在治疗靶点提供了新的见解。
{"title":"Expression of CD45 in non-hematopoietic cells: implications in regenerative medicine and disease management.","authors":"Madhurima Das, Prajakta Teli, Anuradha Vaidya, Vaijayanti Kale","doi":"10.1080/17460751.2024.2378627","DOIUrl":"10.1080/17460751.2024.2378627","url":null,"abstract":"<p><p>CD45 plays a crucial role in the regulation of hematopoiesis. However, a comprehensive understanding of its role in <i>non-hematopoietic</i> cells is lacking. Several tissue precursors express CD45, indicating its crucial role in tissue regeneration. These precursors would fall prey to the recent therapies involving CD45 as a target. CD45<sup>+</sup> double-positive tumor cells contribute to cancer progression, but whether CD45 is involved in the process needs to be investigated. Recently, we showed that aging induces CD45 expression in mesenchymal stromal cells and affects their differentiation potential. In this review, we, for the first time, unravel the important implications of the expression of CD45 in <i>non-hematopoietic</i> cells and provide novel insights into its potential therapeutic target in regenerative medicine and disease management.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141760649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the readiness of the Irish healthcare system to adopt advanced therapies: a scoping review protocol. 探索爱尔兰医疗系统采用先进疗法的准备情况:范围界定审查协议。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2024-01-01 Epub Date: 2024-07-16 DOI: 10.1080/17460751.2024.2368352
Isabella Devine, Clarice O'Brien, David Mockler, Cormac Kennedy, Gerry Hughes, Martina Hennessy

Aim: Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury. However, ATMP adoption requires adjustments to current clinical practices and frameworks. This study investigates the readiness of the Irish healthcare system to adopt licensed ATMPs. Materials & methods: Scoping review, guided by the preferred reporting items for systematic reviews and meta-analyses - scoping review extension. A systematic search of English articles from 2013 to 2023 (published and grey literature) will be conducted.Results: Findings will be presented via narrative summary, graphical and tabular formats.Discussion: Review findings will be discussed in the context of recommendations that will inform national policy and strategy on the adoption of ATMPs in Ireland.

目的:先进治疗药物产品(ATMP)是基于基因、组织或细胞的人类用药。它们为治疗疾病和损伤提供了突破性的新机遇。然而,采用 ATMP 需要对当前的临床实践和框架进行调整。本研究调查了爱尔兰医疗系统采用获得许可的 ATMP 的准备情况。材料与方法:范围界定审查,以系统审查和荟萃分析的首选报告项目为指导--范围界定审查扩展。将对 2013 年至 2023 年的英文文章(已发表和灰色文献)进行系统检索。结果:研究结果将以叙述性摘要、图表和表格的形式呈现。讨论:将结合相关建议讨论综述结果,这些建议将为爱尔兰采用 ATMP 的国家政策和战略提供参考。
{"title":"Exploring the readiness of the Irish healthcare system to adopt advanced therapies: a scoping review protocol.","authors":"Isabella Devine, Clarice O'Brien, David Mockler, Cormac Kennedy, Gerry Hughes, Martina Hennessy","doi":"10.1080/17460751.2024.2368352","DOIUrl":"10.1080/17460751.2024.2368352","url":null,"abstract":"<p><p><b>Aim:</b> Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury. However, ATMP adoption requires adjustments to current clinical practices and frameworks. This study investigates the readiness of the Irish healthcare system to adopt licensed ATMPs. <b>Materials & methods:</b> Scoping review, guided by the preferred reporting items for systematic reviews and meta-analyses - scoping review extension. A systematic search of English articles from 2013 to 2023 (published and grey literature) will be conducted.<b>Results:</b> Findings will be presented via narrative summary, graphical and tabular formats.<b>Discussion:</b> Review findings will be discussed in the context of recommendations that will inform national policy and strategy on the adoption of ATMPs in Ireland.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11370901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring stem cell therapies: an interview with Darius Widera. 探索干细胞疗法:专访达柳斯-维德拉。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2024-01-01 Epub Date: 2024-07-18 DOI: 10.1080/17460751.2024.2375104
Darius Widera
{"title":"Exploring stem cell therapies: an interview with Darius Widera.","authors":"Darius Widera","doi":"10.1080/17460751.2024.2375104","DOIUrl":"10.1080/17460751.2024.2375104","url":null,"abstract":"","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming organ transplantation with regenerative medicine: an interview with Giuseppe Orlando. 用再生医学转化器官移植:采访朱塞佩·奥兰多。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2024-01-01 Epub Date: 2023-11-13 DOI: 10.2217/rme-2023-0204
Giuseppe Orlando

Giuseppe Orlando is an Associate Professor of Surgery and a kidney and pancreas transplant surgeon scientist at Wake Forest University School of Medicine (Winston-Salem, North Carolina), and the President Elect of the Cell Transplant and Regenerative Medicine Society. With a research interest in bioengineering and the regeneration of transplantable organs, Giuseppe's work seeks to establish the link between transplant medicine and regenerative medicine.

Giuseppe Orlando是维克森林大学医学院(Winston-Salem, North Carolina)的外科副教授和肾脏和胰腺移植外科医生,也是细胞移植和再生医学协会的当选主席。朱塞佩的研究兴趣是生物工程和可移植器官的再生,他的工作旨在建立移植医学和再生医学之间的联系。
{"title":"Transforming organ transplantation with regenerative medicine: an interview with Giuseppe Orlando.","authors":"Giuseppe Orlando","doi":"10.2217/rme-2023-0204","DOIUrl":"10.2217/rme-2023-0204","url":null,"abstract":"<p><p>Giuseppe Orlando is an Associate Professor of Surgery and a kidney and pancreas transplant surgeon scientist at Wake Forest University School of Medicine (Winston-Salem, North Carolina), and the President Elect of the Cell Transplant and Regenerative Medicine Society. With a research interest in bioengineering and the regeneration of transplantable organs, Giuseppe's work seeks to establish the link between transplant medicine and regenerative medicine.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89719378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Industry updates from the field of stem cell research and regenerative medicine in September 2023. 2023年9月来自干细胞研究和再生医学领域的行业更新。
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2024-01-01 Epub Date: 2023-12-07 DOI: 10.2217/rme-2023-0217
Dusko Ilic, Mirjana Liovic

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in September 2023.

根据公开信息和非学术机构新闻稿汇编的干细胞研究和再生医学领域的最新进展。
{"title":"Industry updates from the field of stem cell research and regenerative medicine in September 2023.","authors":"Dusko Ilic, Mirjana Liovic","doi":"10.2217/rme-2023-0217","DOIUrl":"10.2217/rme-2023-0217","url":null,"abstract":"<p><p>Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in September 2023.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138499282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experimental and computational approach to establish fit-for-purpose cell viability assays. 通过实验和计算方法建立适用的细胞活力测定方法。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2024-01-01 Epub Date: 2024-01-22 DOI: 10.2217/rme-2023-0154
Laura Pierce, Hidayah Anderson, Swarnavo Sarkar, Steven R Bauer, Sumona Sarkar

Aim: Cell viability assays are critical for cell-based products. Here, we demonstrate a combined experimental and computational approach to identify fit-for-purpose cell assays that can predict changes in cell proliferation, a critical biological response in cell expansion. Materials & methods: Jurkat cells were systematically injured using heat (45 ± 1°C). Cell viability was measured at 0 h and 24 h after treatment using assays for membrane integrity, metabolic function and apoptosis. Proliferation kinetics for longer term cultures were modeled using the Gompertz distribution to establish predictive models between cell viability results and proliferation. Results & conclusion: We demonstrate an approach for ranking these assays as predictors of cell proliferation and for setting cell viability specifications when a particular proliferation response is required.

目的:细胞活力测定对细胞产品至关重要。在此,我们展示了一种实验与计算相结合的方法,以确定可预测细胞增殖(细胞扩增过程中的一种关键生物反应)变化的适用细胞检测方法。材料与方法使用热(45 ± 1°C)对 Jurkat 细胞进行系统损伤。处理后 0 小时和 24 小时,使用膜完整性、代谢功能和细胞凋亡测定法测量细胞活力。使用贡珀兹分布对长期培养的增殖动力学进行建模,以建立细胞存活率结果与增殖之间的预测模型。结果与结论:我们展示了一种方法,可将这些检测结果作为细胞增殖的预测指标进行排序,并在需要特定增殖反应时设定细胞存活率规格。
{"title":"Experimental and computational approach to establish fit-for-purpose cell viability assays.","authors":"Laura Pierce, Hidayah Anderson, Swarnavo Sarkar, Steven R Bauer, Sumona Sarkar","doi":"10.2217/rme-2023-0154","DOIUrl":"10.2217/rme-2023-0154","url":null,"abstract":"<p><p><b>Aim:</b> Cell viability assays are critical for cell-based products. Here, we demonstrate a combined experimental and computational approach to identify fit-for-purpose cell assays that can predict changes in cell proliferation, a critical biological response in cell expansion. <b>Materials & methods:</b> Jurkat cells were systematically injured using heat (45 ± 1°C). Cell viability was measured at 0 h and 24 h after treatment using assays for membrane integrity, metabolic function and apoptosis. Proliferation kinetics for longer term cultures were modeled using the Gompertz distribution to establish predictive models between cell viability results and proliferation. <b>Results & conclusion:</b> We demonstrate an approach for ranking these assays as predictors of cell proliferation and for setting cell viability specifications when a particular proliferation response is required.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139513560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Signal transduction pathways alter the molecular cargo of extracellular vesicles: implications in regenerative medicine. 信号转导通路改变细胞外囊泡的分子货物:在再生医学中的意义。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2023-12-01 Epub Date: 2023-12-07 DOI: 10.2217/rme-2023-0183
Prajakta Teli, Anuradha Vaidya, Vaijayanti Kale

Extracellular vesicles (EVs) possess regenerative properties and are also considered as future vaccines. All types of cells secrete EVs; however, the amount of EVs secreted by the cells varies under various physiological as well as pathological states. Several articles have reviewed the molecular composition and potential therapeutic applications of EVs. Likewise, the 'sorting signals' associated with specific macromolecules have also been identified, but how the signal transduction pathways prevailing in the parent cells alter the molecular profile of the EVs or the payload they carry has not been sufficiently reviewed. Here, we have specifically discussed the implications of these alterations in the macromolecular cargo of EVs for their therapeutic applications in regenerative medicine.

细胞外囊泡(EVs)具有再生特性,也被认为是未来的疫苗。所有类型的细胞都分泌ev;然而,在不同的生理和病理状态下,细胞分泌的ev数量是不同的。一些文章综述了ev的分子组成和潜在的治疗应用。同样,与特定大分子相关的“分类信号”也已被确定,但在亲本细胞中普遍存在的信号转导途径如何改变ev的分子特征或它们携带的有效载荷尚未得到充分的审查。在这里,我们特别讨论了电动汽车大分子货物中这些改变对其在再生医学中的治疗应用的影响。
{"title":"Signal transduction pathways alter the molecular cargo of extracellular vesicles: implications in regenerative medicine.","authors":"Prajakta Teli, Anuradha Vaidya, Vaijayanti Kale","doi":"10.2217/rme-2023-0183","DOIUrl":"10.2217/rme-2023-0183","url":null,"abstract":"<p><p>Extracellular vesicles (EVs) possess regenerative properties and are also considered as future vaccines. All types of cells secrete EVs; however, the amount of EVs secreted by the cells varies under various physiological as well as pathological states. Several articles have reviewed the molecular composition and potential therapeutic applications of EVs. Likewise, the 'sorting signals' associated with specific macromolecules have also been identified, but how the signal transduction pathways prevailing in the parent cells alter the molecular profile of the EVs or the payload they carry has not been sufficiently reviewed. Here, we have specifically discussed the implications of these alterations in the macromolecular cargo of EVs for their therapeutic applications in regenerative medicine.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138499283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Industry updates from the field of stem cell research and regenerative medicine in August 2023. 2023年8月,干细胞研究和再生医学领域的行业更新。
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2023-12-01 Epub Date: 2023-10-03 DOI: 10.2217/rme-2023-0181
Dusko Ilic, Mirjana Liovic

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in August 2023.

2023年8月,根据非学术机构的公开信息和新闻稿汇编了干细胞研究和再生医学领域的最新进展。
{"title":"Industry updates from the field of stem cell research and regenerative medicine in August 2023.","authors":"Dusko Ilic, Mirjana Liovic","doi":"10.2217/rme-2023-0181","DOIUrl":"10.2217/rme-2023-0181","url":null,"abstract":"<p><p>Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in August 2023.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41132510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved neurological function in a patient with complete spinal cord injury through bone marrow mesenchymal stem cells implantation: a case report. 骨髓间充质干细胞移植改善完全性脊髓损伤患者神经功能1例报告。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2023-12-01 Epub Date: 2023-11-22 DOI: 10.2217/rme-2023-0120
Ying-Chuan Kuan, Shinn-Zong Lin, Tsung-Lang Chiu, Hsiang-Yi Hung

Aim: Spinal cord injury (SCI) can cause severe disability. Several clinical trials of stem-cell based therapies are ongoing. We describe our experience of bone marrow mesenchymal stem cell (BMSC) therapy in a patient with complete SCI in the chronic stage. Case report: A 25-year-old man with complete SCI at T6 level presented with paraplegia for 5 years. We transplanted autologous BMSCs intramedullary. After 12 months follow-up, his Barthel index score was noticeably improved from severe to moderate dependency, and the sensation level improved from T7 to S5, but no improvement of motor function. Conclusion: Autologous BMSCs are potentially safe for patients with complete SCI in the chronic stage and may improve neurological function and quality of life.

目的:脊髓损伤可导致严重的残疾。一些基于干细胞疗法的临床试验正在进行中。我们描述了我们的经验,骨髓间充质干细胞(BMSC)治疗患者的完全性脊髓损伤在慢性期。病例报告:一名25岁男性,完全性脊髓损伤在T6水平表现为截瘫5年。我们在髓内移植自体骨髓间充质干细胞。随访12个月后,患者Barthel指数评分由重度依赖改善至中度依赖,感觉水平由T7改善至S5,但运动功能无明显改善。结论:自体骨髓间充质干细胞对于慢性完全性脊髓损伤患者是潜在安全的,并可能改善神经功能和生活质量。
{"title":"Improved neurological function in a patient with complete spinal cord injury through bone marrow mesenchymal stem cells implantation: a case report.","authors":"Ying-Chuan Kuan, Shinn-Zong Lin, Tsung-Lang Chiu, Hsiang-Yi Hung","doi":"10.2217/rme-2023-0120","DOIUrl":"10.2217/rme-2023-0120","url":null,"abstract":"<p><p><b>Aim:</b> Spinal cord injury (SCI) can cause severe disability. Several clinical trials of stem-cell based therapies are ongoing. We describe our experience of bone marrow mesenchymal stem cell (BMSC) therapy in a patient with complete SCI in the chronic stage. <b>Case report:</b> A 25-year-old man with complete SCI at T6 level presented with paraplegia for 5 years. We transplanted autologous BMSCs intramedullary. After 12 months follow-up, his Barthel index score was noticeably improved from severe to moderate dependency, and the sensation level improved from T7 to S5, but no improvement of motor function. <b>Conclusion:</b> Autologous BMSCs are potentially safe for patients with complete SCI in the chronic stage and may improve neurological function and quality of life.</p>","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138291702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern regenerative medicine dictionary: an augmented guide to biotherapy. 现代再生医学词典:生物疗法的增强指南。
IF 2.4 4区 医学 Q4 CELL & TISSUE ENGINEERING Pub Date : 2023-12-01 Epub Date: 2023-11-14 DOI: 10.2217/rme-2023-0200
Andre Terzic
{"title":"Modern regenerative medicine dictionary: an augmented guide to biotherapy.","authors":"Andre Terzic","doi":"10.2217/rme-2023-0200","DOIUrl":"10.2217/rme-2023-0200","url":null,"abstract":"","PeriodicalId":21043,"journal":{"name":"Regenerative medicine","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10782411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92156317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Regenerative medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1